samedan logo
 
 
 
spacer
home > pmps > summer 2003 > sealing technology for active pharmaceutical ingredients manufacture
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Sealing Technology for Active Pharmaceutical Ingredients Manufacture

New developments in perfluoroelastomers are setting the standard for sealing in the manufacture and storage of active pharmaceutical ingredients. This article reviews the growing popularity of these elastomers and their application in total containment systems.

Primary pharmaceutical manufacturers are faced with a problem - how to handle active pharmaceutical ingredients (APIs) and intermediates without risk to the health of their workers arising from processing leaks or breaches in containment during manufacture? Moreover, to meet good manufacturing practice (GMP) regulations for API manufacture, manufacturing operations should not compromise API integrity through poor hygiene standards and cross contamination. To overcome these issues seals are used in pumps, valves and pipe work on the plant and in intermediate bulk containers (IBCs) used for the transportation of raw materials and intermediates.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By David Holt, International Business Manager at Precision Polymer Engineering Ltd

David Holt is International Business Manager at high performance seals and mouldings specialist, Precision Polymer Engineering Ltd. He is responsible for developing global markets for PPE's perfluoroelastomer, Perlast®, in the chemical, pharmaceutical and semiconductor industries. David joined Precision Polymer Engineering in 1998 and is a member of the Chartered Institute of Marketing and the Institute of Incorporated Engineers.

spacer
David Holt
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Safe’n’Spray: A Winner at CPhI Festival of Pharma

Nemera’s concept device Safe'n'SprayTM was rewarded under the category 'Excellence in Pharma - Drug Delivery Devices'
More info >>

White Papers

Characterisation of Biopharmaceutical Proteins

Reading Scientific Services Ltd (RSSL)

Over the next five years it is anticipated that there is going to be an explosion in the numbers of biosimilar products coming to market as patents expire. Consequently, in line with regulatory guidance, there will be a commensurate need to provide full characterisation of such biopharmaceuticals. The purpose of this article is to describe the array of the more common techniques used in biopharmaceutical characterisation (typically of protein or polypeptide). For full characterisation of a protein, the protein�s primary, secondary and tertiary structure as well as its physiochemical properties should be assessed.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement